Trials / Completed
CompletedNCT04584736
To Evaluate the Efficacy and Safety in Patients With Primary Hypercholesterolemia
To Evaluate the Efficacy and Safety of Combination Therapy of Pitavastatin and Ezetimibe Versus Monotherapy of Pitavastatin in Patients With Primary Hypercholesterolemia
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 283 (actual)
- Sponsor
- JW Pharmaceutical · Industry
- Sex
- All
- Age
- 19 Years – 79 Years
- Healthy volunteers
- Not accepted
Summary
To Evaluate the Efficacy and Safety of Combination Therapy of Pitavastatin and Ezetimibe Versus Monotherapy of Pitavastatin in Patients With Primary Hypercholesterolemia.
Detailed description
A Multi-center, Randomized, Double-blinded, Active-controlled, Factorial Design Phase 3 Clinical Trial
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Livalo, Ezetrol | Pitavastatin+Ezetimibe Pitavastatin |
Timeline
- Start date
- 2019-06-11
- Primary completion
- 2020-07-16
- Completion
- 2020-10-12
- First posted
- 2020-10-14
- Last updated
- 2021-12-01
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT04584736. Inclusion in this directory is not an endorsement.